The Latin America, Middle East and Africa Lipase Food Enzymes Market would witness market growth of 12.8% CAGR during the forecast period (2023-2029).
The development of new food categories and the increase in the number of nuclear families. The requirement for food enzymes from healthy food product manufacturers is driven by various factors. Enzyme-assisted products have high nutritional value and aid in the digestion of food. They also facilitate the breakdown of the food consumed into essential proteins, fats, and carbohydrates, providing optimal nutrition.
The evolving population is increasingly gravitating towards value-added food categories and prioritizing health, resulting in an important effect on the nutritional products demand like lipase food products. The growing demand for nutritionally rich and healthy food among consumers has increased the manufacturing of food processors. The lipase food enzymes market is experiencing growth due to the increasing demand for nutritional food products that meet the dietary needs of the population. Nutritional food manufacturers include enzymes in their goods to meet this demand.
The Middle East and Africa’s rising dietary demand for products made from animals is anticipated to fuel market expansion throughout the forecast period. A rise in the demand for more effective animal health services to promote food safety has also been brought on by the region’s large increase in animal farming. The regional demand for lipase in animal feed has expanded due to the microbiology field’s quick advances. In addition, the demand for lipase in animal feed will be influenced by rising consumer awareness of the advantages of animal health. As a result, the regional lipase food enzymes market will grow exponentially in the coming years.
The Brazil market dominated the LAMEA Lipase Food Enzymes Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $15.5 million by 2029. The Argentina market is estimated to grow a CAGR of 13.4% during (2023 - 2029). Additionally, The UAE market would showcase a CAGR of 12.5% during (2023 - 2029).
Based on Application, the market is segmented into Food & Beverage Processing, Animal Feed, and Others. Based on Food & Beverage Processing Type, the market is segmented into Bakery Products, Dairy Products, and Others. Based on Form, the market is segmented into Powder and Liquid. Based on Source, the market is segmented into Microorganisms, Animals and Plants. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Chr. Hansen Holding A/S, Associated British Foods PLC (Wittington Investments Limited), Biocatalysts Limited (Brain Biotech AG), Novozymes A/S (Novo Holdings A/S), BASF SE, Infinita Biotech Private Limited, Antozyme Biotech Pvt Ltd, Jiangsu Yiming Biological Technology Co., Ltd., Creative Enzymes and Enzyme Development Corporation.
Scope of the Study
Market Segments covered in the Report:
• Food & Beverage Processing
o Bakery Products
o Dairy Products
• Animal Feed
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Chr. Hansen Holding A/S
• Associated British Foods PLC (Wittington Investments Limited)
• Biocatalysts Limited (Brain Biotech AG)
• Novozymes A/S (Novo Holdings A/S)
• BASF SE
• Infinita Biotech Private Limited
• Antozyme Biotech Pvt Ltd
• Jiangsu Yiming Biological Technology Co., Ltd.
• Creative Enzymes
• Enzyme Development Corporation
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free